Kobayashi Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kobayashi Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kobayashi Pharmaceutical Co Ltd Strategy Report
- Understand Kobayashi Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kobayashi Pharmaceutical Co Ltd (Kobayashi) manufactures and distributes pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, eyeglasses cleaners, body warmers and cooling gel sheets for the forehead. It also offers health food products, dietary food products, nutritional supplements, skincare products, medical equipment, devices and ventilators to medical institutes and hospitals, transportation, insurance, production, advertising planning, synthetic resin products and real estate management services. The company operates through subsidiaries and has a presence in North America, Europe, and Asia. Kobayashi is headquartered in Chuo, Osaka, Japan.
Headquarters
Japan
Address
Kdx Kobayashi Doshomachi Bldg., 4-4-10, Dosho-Machi, Chuo-Ku, Osaka-Shi, 541-0045
Website
www.kobayashi.co.jp
Telephone
81 6 62311144
No of Employees
3,534
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4967 (TYO)
Revenue (2022)
$1.3B
4.3%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
1.6%
(2022 vs 2021)
Market Cap*
$2.9B
Net Profit Margin (2022)
XYZ
-2.6%
(2022 vs 2021)
* As of and is in US$
Kobayashi Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Consumer | - | Bluelet |
| Lens cleaner | Real Estate Management | Sawaday |
| Oral Hygiene Products | Insurance | Daikomaru |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Product Recall | In March, the company recalled cholesterol-lowering supplement pills containing red yeast rice because of health risk. |
| 2023 | New Products/Services | In November, the company launched Language Academy, an online language-learning platform. |
| 2023 | New Products/Services | In November, the company launched HERP Hire, the digital human resources recruitment management system. |
Competitor Comparison
| Key Parameters | Kobayashi Pharmaceutical Co Ltd | Astellas Pharma Inc | Daiichi Sankyo Co Ltd | Mitsubishi Tanabe Pharma Corp | Shionogi & Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Osaka-Shi | Chuo-Ku | Chuo-Ku | Osaka | Osaka-Shi |
| State/Province | Osaka | Tokyo | Tokyo | Osaka | Osaka |
| No. of Employees | 3,534 | 14,484 | 17,435 | 6,697 | 5,680 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kazumasa Kobayashi | Director; Chairman; Chief Executive Officer | Executive Board | 2004 | 84 |
| Akihiro Kobayashi | Chief Operating Officer; Chief Executive Officer; Director; President | Executive Board | 2013 | 52 |
| Satoshi Yamane | Director; General Manager- Group Headquarters; Senior Managing Director; Chief Financial Officer - Unit | Executive Board | - | - |
| Naoki Ayabe | General Manager- Sales Headquarters; Managing Executive Officer | Senior Management | - | - |
| Tetsushi Nishioka | Executive Officer; Chief Director - Manufacturing | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward